We have observed
10 EP applications
has served for within the last five+ years.
(We consider all applications which have an EP A1 or A2 publication dated after April 25, 2013).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
Cycloalkane carboxylic acid derivatives as CXCR3 receptor antagonists
NOVEL PROCESS FOR THE PREPARATION OF DRONEDARONE
PROCESS FOR THE PREPARATION OF TRAVOPROST
REDUCTIVE AMINATION PROCESS FOR PREPARATION OF DRONEDARONE USING AMINE INTERMEDIARY COMPOUND
PROCESS FOR PREPARATION OF DRONEDARONE BY MESYLATION
PROCESS FOR PREPARATION OF DRONEDARONE BY N-BUTYLATION
Process for preparation of dronedarone by the use of dibutylaminopropanol reagent
METHOD FOR PREPARING PHENYLOXYMETHYL-NITRO-IMIDAZOLE DERIVATIVES AND USE OF SAME
NEW PROCESS FOR THE PREPARATION OF HIGH PURITY PROSTAGLANDINS